About
Team
Pipeline
OPN-2853
OPN-6602
DEGRADERS
OPN-FMRP
OPN-7486
OPN-9840
OPN-9627
Patients
News
Press Releases
Publications
& Posters
Careers
Investors
Contact
General information
info@opnabio.com
Investor inquiries
bd@opnabio.com
Media and BD inquiries
bd@opnabio.com
Presentation
Select PROGRAMS
All Programs
Multi-Functional Degraders
(1)
OPN-2853
(10)
OPN-51107
(17)
OPN-6602
(3)
OPN-7486
(5)
OPN-TEAD
(2)
Select Dates
All Dates
2025
(3)
2024
(4)
2023
(3)
2022
(1)
2021
(3)
2020
(3)
2019
(7)
2018
(4)
2017
(3)
2016
(2)
2015
(3)
December 16, 2015
Presentation
A novel inhibitor of BET family bromodomains demonstrates in vivo and in vitro potency in B-cell malignancy
AUTHORS
El-Gamal, et al
Programs
OPN-51107
Download PDF